Publications
Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases.
2013
Thorax
Tebruegge M, Salo E, Ritz N, et al.
DOI:
10.1136/thoraxjnl-2012-202824
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.
2013
Eur Respir J
Hoefsloot W, van Ingen J, Andrejak C, et al.
DOI:
10.1183/09031936.00149212
TBNET - Collaborative research on tuberculosis in Europe.
2012
Eur J Microbiol Immunol (Bp)
Giehl C, Lange C, Duarte R, et al. TBNET - Collaborative research on tuberculosis in Europe.
DOI:
10.1556/EuJMI.2.2012.4.4
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement.
2012
Eur Respir J
Bumbacea D, Arend SM, Eyuboglu F, et al.
DOI:
10.1183/09031936.00000712
Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study.
2012
Am J Respir Crit Care Med
Basu Roy R, Sotgiu G, Altet-Gómez N, et al.
DOI:
10.1164/rccm.201201-0026OC
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.
2011
Eur Respir J
Sester M, Sotgiu G, Lange C, et al.
DOI:
10.1183/09031936.00114810
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis.
2011
Tuberculosis (Edinb)
Ruhwald M, Dominguez J, Latorre I, et al.
DOI:
10.1016/j.tube.2011.01.001
Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
2011
Eur Respir J
Diel R, Goletti D, Ferrara G, et al.
DOI:
10.1183/09031936.00115110
Development of a standardised tool to survey MDR-/XDR-TB case management in Europe.
2010
Eur Respir J
Sotgiu G, Centis R, D’ambrosio L, et al.
DOI:
10.1183/09031936.00186409
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement.
2010
Eur Respir J
Solovic I, Sester M, Gomez-Reino JJ, et al.
DOI:
10.1183/09031936.00028510
Tuberculosis contact investigation in low prevalence countries: a European consensus.
2010
Eur Respir J
Erkens CGM, Kamphorst M, Abubakar I, et al.
DOI:
10.1183/09031936.00201609
Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study.
2010
Arch Dis Child
Bamford ARJ, Crook AM, Clark JE, et al.
DOI:
10.1136/adc.2009.169805
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
2009
J Antimicrob Chemother
Sotgiu G, Lange C, Richardson MD, et al.
DOI:
10.1093/jac/dkp265
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.
2009
Eur Respir J
Sotgiu G, Ferrara G, Matteelli A, et al.
DOI:
10.1183/09031936.00168008
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment.
2009
Clin Infect Dis
Migliori GB, Sotgiu G, D’Arcy Richardson M, et al.
DOI:
10.1086/600060